Extensive evidence showed that miR-378 attenuated ischemic injury in cardiomyocytes by inhibiting caspase-3 expression, representing a potential novel treatment for apoptosis and ischemic heart disease [16]. This evidence concerns the gene CASP3 and coronary artery disorder.